Aquestive Therapeutics, Inc. (AQST)
5.225
+0.12
(+2.25%)
USD |
NASDAQ |
Sep 01, 16:00
5.225
0.00 (0.00%)
After-Hours: 16:32
Aquestive Therapeutics Total Long Term Debt (Quarterly) : 148.26M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 148.26M |
| March 31, 2026 | 132.92M |
| December 31, 2025 | 130.81M |
| September 30, 2025 | 128.26M |
| June 30, 2025 | 125.69M |
| March 31, 2025 | 124.02M |
| December 31, 2024 | 121.43M |
| September 30, 2024 | 118.95M |
| June 30, 2024 | 116.43M |
| March 31, 2024 | 114.72M |
| December 31, 2023 | 97.42M |
| September 30, 2023 | 109.17M |
| June 30, 2023 | 109.23M |
| March 31, 2023 | 113.38M |
| December 31, 2022 | 122.49M |
| September 30, 2022 | 119.46M |
| June 30, 2022 | 118.36M |
| March 31, 2022 | 118.03M |
| December 31, 2021 | 115.81M |
| Date | Value |
|---|---|
| September 30, 2021 | 101.05M |
| June 30, 2021 | 96.38M |
| March 31, 2021 | 92.98M |
| December 31, 2020 | 88.72M |
| September 30, 2020 | 65.14M |
| June 30, 2020 | 64.74M |
| March 31, 2020 | 64.35M |
| December 31, 2019 | 60.34M |
| September 30, 2019 | 59.78M |
| June 30, 2019 | 47.43M |
| March 31, 2019 | 47.59M |
| December 31, 2018 | 47.20M |
| September 30, 2018 | 46.80M |
| June 30, 2018 | 46.43M |
| March 31, 2018 | 45.96M |
| December 31, 2017 | 45.51M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 0.122M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |
| Johnson & Johnson | 37.34B |